Stat News
STAT+: The PBMs fight back, and arbitration doesn’t lose
We unpack the contentious fight over drug price transparency.
S
Source
Stat News
Read full article at Stat News
Opens original article in a new tab
Advertisement
AI Bias Analysis
4 models · Takes ~15 seconds
Related Health Stories
Stat News
STAT+: Eli Lilly’s $3.25 billion acquisition of Kelonia Therapeutics caps startup’s tortuous ride
Kelonia Therapeutics, a small biotech company, long struggled to stay afloat. Now it's been acquired by Eli Lilly for $3.25 billion.
MedPage Today
Make the Diagnosis: Is This Eruption Related to the Patient's Acne? His Ulcerative Colitis?
(MedPage Today) --
MedPage Today
Trump Signs Order to Speed Review of Controversial Ibogaine, Other Psychedelics
(MedPage Today) -- President Trump on Saturday directed his administration to speed up reviews of certain psychedelic drugs, including ibogaine, which recently has been embraced by combat veterans and conservative lawmakers despite having serious...
HealthDaily Composite
Stat News
STAT+: Finally cracking KRAS as a druggable target
The Breakthrough Prize winners, Trump's psychedelics executive order, and more biotech news from The Readout